Morgan Adam
Insider CIK 1964335 · ALIM Director, 10% owner · JSPR 10% owner · HRTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2026-01-30 | 2026-02-03 | 53,960 | — | $0 | 123,737 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy deriv | 2025-08-08 | 2025-08-12 | 70,012 | $15.00 | $1.05M | 70,012 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy | 2025-08-08 | 2025-08-12 | 1,766,546 | $1.50 | $2.65M | 8,753,290 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-31 | 2025-02-04 | 35,900 | — | $0 | 35,900 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2025-01-31 | 2025-02-04 | 17,950 | — | $0 | 69,777 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-30 | 2025-02-03 | 35,900 | $1.73 | $62.1K | 35,900 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2025-01-30 | 2025-02-03 | 17,950 | — | $0 | 69,777 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | D To issuer deriv | 2024-09-16 | 2024-09-16 | 800,000 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | D To issuer deriv | 2024-09-16 | 2024-09-16 | 1,825 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | D To issuer deriv | 2024-09-16 | 2024-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | D To issuer | 2024-09-16 | 2024-09-16 | 9,429,808 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | D To issuer | 2024-09-16 | 2024-09-16 | 4,178,725 | — | $0 | 0 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy | 2024-02-08 | 2024-02-09 | 350,000 | $12.95 | $4.53M | 1,188,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2024-01-19 | 2024-01-19 | 83,685 | — | $0 | 83,685 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2024-01-19 | 2024-01-19 | 13,948 | — | $0 | 51,827 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2023-10-02 | 2023-10-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2023-08-15 | 2023-08-17 | 8,117 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2023-08-15 | 2023-08-17 | 7,000 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2023-08-15 | 2023-08-17 | 6,000 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2023-08-15 | 2023-08-17 | 4,845,392 | $1.70 | $8.24M | 6,505,046 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2023-08-15 | 2023-08-17 | 4,178,725 | $1.70 | $7.10M | 4,178,725 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2023-08-15 | 2023-08-17 | 2,924,762 | $2.10 | $6.14M | 9,429,808 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy deriv | 2023-07-21 | 2023-07-25 | 1,162,891 | $1.37 | $1.59M | 1,162,891 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy | 2023-07-21 | 2023-07-25 | 2,486,744 | $1.37 | $3.41M | 6,986,744 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy deriv | 2023-05-17 | 2023-05-19 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy deriv | 2023-05-17 | 2023-05-19 | 8,117 | — | $0 | 8,117 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other deriv | 2023-05-17 | 2023-05-19 | 2,057,143 | — | $0 | 800,000 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2023-05-17 | 2023-05-19 | 1,401,901 | $1.70 | $2.38M | 1,659,654 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2023-03-26 | 2023-03-28 | 1,825 | — | $0 | 1,825 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2023-02-22 | 2023-02-24 | 227,272 | — | $0 | 227,272 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2023-02-22 | 2023-02-24 | 37,879 | — | $0 | 37,879 | SEC↗ |